Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Sonnet Biotherapeutics (SONN) Q4 2023 Earnings
SONN
14
Feb
Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.9
-0.64
-0.39
-0.13
Details
Expected EPS
-0.9
Actual EPS
-0.31
Surprise EPS
0.59
Surprise Percent
+65.56%
Description
Sonnet Biotherapeutics (SONN) has reported earnings of -0.31 per share for Q4 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login